Hospital
Pacifica of the Valley Corporation
Pacifica of the Valley Corporation was paid $987K by Medicaid between Jan 2018 and Nov 2024, across 71 billing codes. Its largest line is 0450, Emergency room services — 36% of everything it billed.
33Billing provider infoPACIFICA OF THE VALLEY CORPORATION
SUN VALLEY, CA 91352
SUN VALLEY, CA 91352
33aNPI1861402935assigned 08/09/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$987K
24GClaims73,101
24DCodes billed71
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#272 of 410
Median peer was paid$6.90M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,056 | $363K | |
| 2019 | 12,098 | $213K | |
| 2020 | 3,892 | $50K | |
| 2021 | 5,039 | $51K | |
| 2022 | 4,952 | $48K | |
| 2023 | 12,601 | $132K | |
| 2024incomplete | 11,463 | $130K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 36% | 10,658 | 9,816 | $357K |
| 70450 | Computed tomography, head or brain; without contrast material | 9.5% | 911 | 881 | $93K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.1% | 377 | 365 | $40K |
| 74150 | 3.7% | 376 | 360 | $37K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.7% | 719 | 694 | $36K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.5% | 1,637 | 1,515 | $34K |
| 80053 | Comprehensive metabolic panel | 3.1% | 4,976 | 4,672 | $31K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2.9% | 1,188 | 1,108 | $29K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.9% | 551 | 511 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.3% | 5,344 | 4,959 | $23K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 2.1% | 360 | 354 | $21K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 978 | 941 | $19K |
59 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.8% | 385 | $18K |
| 82553 | 1.8% | 2,029 | $18K | |
| 72192 | 1.7% | 298 | $17K | |
| 84484 | 1.5% | 2,435 | $15K | |
| 94760 | 1.4% | 1,975 | $14K | |
| 71046 | Radiologic examination, chest; 2 views | 1.4% | 881 | $13K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 801 | $13K |
| 80305 | <1% | 1,590 | $10K | |
| 71045 | Radiologic examination, chest; single view | <1% | 948 | $9K |
| 82150 | <1% | 2,652 | $9K | |
| 99199 | Unlisted special service, procedure or report | <1% | 1,838 | $9K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,636 | $9K |
| 85730 | <1% | 2,634 | $9K | |
| 83880 | <1% | 516 | $8K | |
| 83690 | <1% | 2,072 | $8K | |
| 81001 | <1% | 4,253 | $8K | |
| J3490 | Unclassified drugs | <1% | 1,838 | $8K |
| 82550 | <1% | 2,021 | $7K | |
| 85610 | <1% | 2,669 | $6K | |
| 81025 | <1% | 1,588 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 101 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 82 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 606 | $2K |
| 94060 | <1% | 69 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 382 | $2K |
| 0270 | <1% | 830 | $2K | |
| 0301 | <1% | 81 | $2K | |
| 99284 | Emergency room visit (serious) | <1% | 114 | $1K |
| 85007 | <1% | 549 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 27 | $1K |
| 99283 | Emergency room visit (moderate) | <1% | 71 | $947.02 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 12 | $864.60 |
| 87040 | <1% | 69 | $846.63 | |
| 0259 | <1% | 1,187 | $842.11 | |
| 87400 | <1% | 175 | $832.57 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 195 | $807.78 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 213 | $773.74 |
| 99285 | Emergency room visit (most serious) | <1% | 75 | $460.44 |
| 73564 | <1% | 15 | $320.50 | |
| 85378 | <1% | 67 | $320.10 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 16 | $307.98 |
| 82948 | <1% | 117 | $307.07 | |
| 96370 | <1% | 21 | $296.20 | |
| 73610 | <1% | 13 | $193.28 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 30 | $153.53 |
| 73130 | <1% | 12 | $142.80 | |
| 86756 | <1% | 14 | $134.72 | |
| 84703 | <1% | 44 | $130.05 | |
| 0250 | <1% | 189 | $129.24 | |
| 99001 | <1% | 1,408 | $128.43 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,704 | $93.71 |
| 96376 | <1% | 14 | $48.51 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14 | $41.04 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 12 | $34.86 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 12 | $30.40 |
| 80371 | <1% | 30 | $18.53 | |
| J7131 | Hypertonic saline solution, 1 ml | <1% | 12 | $0.41 |
| 80320 | 0% | 370 | $0.00 | |
| 0272 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWATKINS, GEORGE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Pacifica of the Valley Corporation | Sun Valley, CA | $1.11M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.